A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
Titel:
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
Auteur:
Newsome, Scott D. Tian, Fan Shoemaker, Thomas Fitzgerald, Kathryn C. Cassard, Sandra D. Fiol, Julie Snoops, Sarah Cooper, David S. Mammen, Jennifer S. R. Bhargava, Pavan Mowry, Ellen M. Calabresi, Peter A.